---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "cB4Ma35zqAEvKmqZayVzFhuOvSgaI4gvVtCp+E01czf4Wrqgo06nA3fEjcSCKRsaS0i23P5iuMZHdEhmS/6xxCjnmVsSYwGddCzI5E+Bdit3JK5o5jhhqezBAzbVj6vJR7OyUwh8ORoHOv7JgV7+5W8Ay21GdY77VLExKUNH5Nb2K8Uk3XqwGMKePV4BxWQI/mjN40DW7CgFp6XPSkcxksJaJOLyi1LhDcM5aVHkeb0m4YxWDBDZbkbPIA92Vva/+vwLkUUDXNsnpJ0RbS6lAlFCRWgsuddH9MyLfkhZ9rOJhyjrvbEaeGupuOPuXVTRfr0asbBs/AO4zehxqE2CxxWx9/ZXUPFwi8OVYIT9Sck=;nfDibFEmpxyNV7LduoqDNA=="
---

